EpiSkin Biotech License helps China to Advance Cosmetics without Animal Testing
Owner/Developer: Human Society International (HSI)
|Country:||United States of America|
Chinese authorities have granted a license for Shanghai EpiSkin Biotechnology Ltd to market its reconstructed human skin model. The development is hailed by Humane Society International’s China team as an important step towards enabling domestic cosmetics companies to replace animal tests with modern in vitro methods, and in so doing, take advantage of the very latest research technologies in product safety. Since China’s Food and Drug Administration introduced regulatory reforms in July, Chinese companies producing ordinary cosmetics no longer need to test finished products on animals, allowing for a substantial reduction in animal testing. The next step will be to increase the availability, uptake and acceptance of new in vitro technologies, and the licensing of EpiSkin marks an important step towards that goal.
|Channel:||Website - Social media|
|Audience:||Scientists - Policy-makers - Regulators - Industry - Researchers - Students - General public - Educators|
|User access:||Open access|
|Updating frequency:||October 6 - 2014|
|Relevance:||Replacement - Reduction|
|Purpose:||Documentation and information|
|Technology/Tools:||Alternative test methods (in vitro)|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.